Basilea Pharmaceutica AG
SIX:BSLN
Basilea Pharmaceutica AG
SIX:BSLN
Price:
43.9 CHF
2.33%
Market Closed
Updated:
May 30, 2024
Basilea Pharmaceutica AG
Other Operating Expenses
|
Basilea Pharmaceutica AG
Other Operating Expenses Peer Comparison
Comparables:
ADCT
ACIU
CRSP
IDIA
KURN
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Operating Expenses
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Operating Expenses
-CHf3.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
Other Operating Expenses
CHf1.2m
|
CAGR 3-Years
960%
|
CAGR 5-Years
312%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Operating Expenses
-CHf6.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Basilea Pharmaceutica AG's Other Operating Expenses?
Other Operating Expenses
0
CHF
0
CHF
Based on the financial report for Dec 31, 2023, Basilea Pharmaceutica AG's Other Operating Expenses amounts to 0 CHF.
You don't have any saved screeners yet
